Coverage is available if you meet strict requirements: BMI 30 (or 27 with comorbidity), failed 2+ other weight loss medications, AND tried semaglutide for at least 6 months
Sustainable lifestyle: The program promotes healthy habits you can maintain for long-term success
Over the past decades, several randomized clinical trials (RCTs) have shown that GLP-1 RAs improve cardiovascular outcomes in patients with type 2 DM (T2DM) who have established CVDs or are at risk, as well as in individuals with CKD [16,17,18,19]
Use in Specific Populations (Off-Label and Emerging Evidence) While the primary indications are well-defined, the powerful metabolic effects of semaglutide have led to investigation in other conditions characterized by insulin resistance and obesity
There are also concerns that an overemphasis on natural remedies may lead to the rejection of evidence-based treatments, potentially compromising patient health outcomes
Learn more about the key factors that healthcare professionals consider, including BMI, weight loss attempts, health issues, psychological well-being, commitment to lifestyle changes, and more